Panel: FDA’s conclusion on BPA safety is flawed

updated 10:20 a.m. ET Oct. 29, 2008

WASHINGTON - An independent panel of science advisers is taking issue with the FDA’s assessment that a controversial chemical is safe.

In a report to the agency, the panel concluded: “The margins of safety identified by FDA as ’adequate’ are, in fact, inadequate.”

The chemical, known as bisphenolA, is used to make plastic baby bottles and sealants for cans that contain food. Environmental groups are seeking to have it banned in products for young children.

The advisers found that the FDA had not considered all the scientific evidence available in concluding that BPA is safe.

MORE FROM MORE HEALTH NEWS

More Health News Section Front

HPV vaccine no longer required for green cards Bits of steel, rubber found in Genzyme drugs FDA tackles drug marketing on social media Chimp attack victim reveals face on Oprah Pfizer drug studies fudged, report says Antibiotic overuse could threaten medicine Using human DNA in animals? UK to study Calif. medical pot shops abound, despite order Scientists halt brain disease with gene therapy FDA launches plan to curb accidental overdoses More Health News Section Front   Add More Health News headlines to your news reader: